It was reported on November 18, that August J Troendle, CEO at Medpace Hldgs (NASDAQ: MEDP) executed a significant insider ...

Discover key takeaways from Privia Health's Q3 2025 earnings: strong EBITDA growth, margin expansion, and 2025 guidance upgrades.

Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the ...

Discover the top 3 undervalued Specialized REITs stocks for Tuesday, November 18 based on AAII’s Stock Grades.

What Happened: GALBREATH's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

Read here for latest insights on Tempus AI (TEM) stock's growth in healthcare AI, breakthrough EBITDA, and valuation ...

CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, ...

Rau said the market views private firms differently from listed ones, adding that growing confidence in Pine Labs’ brand ...

Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year ...

For the nine-month period, Makhazen recorded revenue of KD 112.6 million, EBITDA of KD 179 million and net profit from ...

BioMar and Schouw & Co have been considering an initial public offering (IPO) for BioMar for over a year. BioMar has been a ...

Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured ...